Dr. Schön, Neymeyr & Partner Patentanwälte Mbb patent opposition analysis

The comprehensive analysis of Dr. Schön, Neymeyr & Partner Patentanwälte Mbb opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Dr. Schön, Neymeyr & Partner Patentanwälte Mbb

Patent NumberTitleApplicantOpposition DateOpposition Company
Method And Device For Estimating The Condition Of An Electrical NetworkSIEMENS AKTIENGESELLSCHAFTJun 24, 2026DR. SCHÖN, NEYMEYR & PARTNER PATENTANWÄLTE MBB
Formulations Of Ag10EIDOS THERAPEUTICS, INC.Jun 23, 2026DR. SCHÖN, NEYMEYR & PARTNER PATENTANWÄLTE MBB
Method Of Synthesizing Thyroid Hormone Analogs And Polymorphs ThereofMADRIGAL PHARMACEUTICALS, INC.Jun 9, 2026DR. SCHÖN, NEYMEYR & PARTNER PATENTANWÄLTE MBB
New Use Of A Combination Of Sacubitril And ValsartanNOVARTIS AGFeb 12, 2026DR. SCHÖN, NEYMEYR & PARTNER PATENTANWÄLTE MBB
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTIS AGJan 29, 2026DR. SCHÖN, NEYMEYR & PARTNER PATENTANWÄLTE MBB
Manufacture Of A Crystalline Pharmaceutical ProductORION CORPORATIONJan 9, 2026DR. SCHÖN, NEYMEYR & PARTNER PATENTANWÄLTE MBB
Crystal Form Of Ozanimod, Crystal Form Of Hydrochloride Thereof, And Preparation Method ThereforRECEPTOS LLCDec 23, 2025DR. SCHÖN, NEYMEYR & PARTNER PATENTANWÄLTE MBB
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTIS AGJul 16, 2025DR. SCHÖN, NEYMEYR & PARTNER PATENTANWÄLTE MBB
Methods For Dose Initiation Of Aripiprazole TreatmentsOTSUKA PHARMACEUTICAL CO., LTD.Jul 1, 2025DR. SCHÖN, NEYMEYR & PARTNER PATENTANWÄLTE MBB
Solid State Forms Of Mavacamten And Process For Preparation ThereofASSIA CHEMICAL INDUSTRIES LTD.Jun 17, 2025DR. SCHÖN, NEYMEYR & PARTNER PATENTANWÄLTE MBB